rs383362
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000402655.6(WWOX):c.725G>T(p.Ser242Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.525 in 1,541,148 control chromosomes in the GnomAD database, including 221,337 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000402655.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WWOX | NM_016373.4 | c.*127G>T | 3_prime_UTR_variant | 9/9 | ENST00000566780.6 | NP_057457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WWOX | ENST00000566780.6 | c.*127G>T | 3_prime_UTR_variant | 9/9 | 1 | NM_016373.4 | ENSP00000457230.1 |
Frequencies
GnomAD3 genomes AF: 0.459 AC: 69715AN: 151992Hom.: 17157 Cov.: 33
GnomAD3 exomes AF: 0.436 AC: 64037AN: 146858Hom.: 15752 AF XY: 0.442 AC XY: 35058AN XY: 79310
GnomAD4 exome AF: 0.532 AC: 739425AN: 1389038Hom.: 204174 Cov.: 82 AF XY: 0.529 AC XY: 362518AN XY: 685916
GnomAD4 genome AF: 0.459 AC: 69747AN: 152110Hom.: 17163 Cov.: 33 AF XY: 0.450 AC XY: 33467AN XY: 74368
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 54% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 50. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at